Pacemaker is a medical device that uses electric shocks to continuously and regularly stimulate the heart muscles to maintain the continuous beating of the heart. Implantable cardioverter defibrillators or automatic implantable cardioverter defibrillators are devices that can be implanted in the body and can perform cardioversion, defibrillation and pacing of the heart. Therefore, the device can correct most life-threatening arrhythmias. For patients at risk of sudden cardiac death due to ventricular fibrillation and ventricular tachycardia, ICD is the first-line treatment and preventive treatment.

Market Analysis and Insights: Global and Japan Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market
This report focuses on global and Japan Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market.
In 2020, the global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Scope and Market Size
Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Pacemakers
Implantable Cardioverter Defibrillators

Segment by Application
Hospitals
Speciality Clinics & Cardiac Centres
Ambulatory centres
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Medtronic Inc.
Boston Scientific
ZOLL Medical Corp.
Asahi Kasei Corp.
Nihon Kohden Corp.
Shree Pacetronix Ltd.
St. Jude Medical, Inc
BIOTRONIK SE & Co. KG
EBR Systems, Inc.
MEDICO S.p.A.
Osypka Medical GmbH
Physio-Control Corp.